A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma
Clinical trial NCT01796171 · COMPLETED
Trial details
- NCT number
- NCT01796171
- Sponsor
- Nordic Nanovector
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2022-10-25
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.